MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.3751
-0.0199
-5.04%
Pre Market: 0.4138 +0.0387 +10.32% 09:10 11/11 EST
OPEN
0.3950
PREV CLOSE
0.3950
HIGH
0.3999
LOW
0.3750
VOLUME
52
TURNOVER
0
52 WEEK HIGH
1.600
52 WEEK LOW
0.3750
MARKET CAP
2.28M
P/E (TTM)
-0.5436
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (1102-1106)?
Weekly Report · 2d ago
RedHill Biopharma Reports RHB-204 MAP-Killing Confirmation
TipRanks · 11/02 12:25
RedHill Biopharma’s RHB-204 shows MAP-killing efficacy in Crohn’s Disease
TipRanks · 11/02 12:10
Redhill Biopharma Announced Confirmation Of RHB-204's Killing Capability On Mycobacterium Avium Subspecies Paratuberculosis And Its Comparability To RHB-104 MAP-Killing
Benzinga · 11/02 12:06
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
PR Newswire · 11/02 12:00
Weekly Report: what happened at RDHL last week (1026-1030)?
Weekly Report · 11/02 09:58
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/28 12:05
'Congo Ebola Cases Top 10,000 as Violence Hits Health Workers' - Bloomberg
Benzinga · 10/27 12:39
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.